No annual revenue total was found in GREEN PLANET BIOENGINEERING CO., LTD.'s SEC filings.
Green Planet Bioengineering Co., Ltd. (GPLB) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances).
Revenue
—
Net income (TTM)
$-41,746
-43.2% vs year-ago TTM
Operating cash flow (TTM)
$-52,896
-78.3% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.00
Dividend per share
None
Shares outstanding
20.01M
+0.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GPLB (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Aventura, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1392449
- Former names
- Mondo Acquisition II, Inc. (until Oct 9, 2008)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| Net income | -$35,842 | -$35,544 | -$47,670 | -$32,533 | -$33,599 |
| Diluted EPS | $0.00 | $0.00 | — | — | — |
| Operating cash flow | -$36,544 | -$35,044 | -$42,670 | -$32,533 | -$33,813 |
| Stockholders' equity | -$500,976 | -$465,134 | -$429,590 | -$381,920 | -$316,458 |
| Cash and investments | $0 | $0 | $0 | $0 | $0 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
All 154 Green Planet Bioengineering Co., Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.